Technology / Scientific & Technical InstrumentsNasdaqCM
$2.11
-0.04 (-1.86%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-9.8M · quality 23.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
20/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$96M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-835.8%
↓Gross Margin
41.6%
↑Debt/Equity
9.85
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2010–2025 · 15 años de histórico normalizado
Revenue CAGR
+6.1%
FCF CAGR
—
FCF margin
-22.1%
FCF / Net income
0.50x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $40.8M · net income $-18.1M · FCF $-9.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | $40.8M | $40.8M | $24.0M | $46.7M | $54.0M | — | — | — | $26.3M | $20.3M | $16.4M | $16.8M | $24.6M | $17.1M | $14.8M | $26.5M | $16.7M |
| Net Income | $-18.1M | $-18.1M | $-31.7M | $-18.4M | $-16.2M | $704000.00 | $11.9M | $2.8M | $-3.7M | $-876754.00 | $-1.3M | $9.7M | $3.3M | $1.3M | $1.5M | $5.0M | $3.0M |
| EBITDA | $-12.9M | $-12.9M | $-27.8M | $-7.7M | $933000.00 | $2.7M | $6.8M | $4.0M | $-993378.00 | $-654457.00 | $-1.4M | $1.5M | $3.5M | $1.1M | $1.4M | $5.1M | $2.7M |
| EPS | -0.40 | -0.40 | -0.72 | -0.50 | -0.44 | 0.02 | 0.35 | 0.08 | -0.12 | -0.03 | -0.04 | 0.29 | 0.10 | 0.04 | 0.04 | 0.15 | 0.10 |
| Gross Margin | 41.6% | 41.6% | 42.4% | 46.6% | 50.5% | — | — | — | 48.4% | 50.6% | 46.9% | 50.8% | 56.0% | 48.3% | 50.6% | 60.1% | 55.0% |
| Operating Margin | -41.2% | -41.2% | -111.3% | -23.5% | -4.4% | — | — | — | -5.6% | -4.0% | -9.7% | 7.3% | 13.5% | 5.7% | 8.6% | 18.8% | 14.7% |
| Net Margin | -44.4% | -44.4% | -132.2% | -39.4% | -30.0% | — | — | — | -14.2% | -4.3% | -7.8% | 57.7% | 13.5% | 7.4% | 9.9% | 18.9% | 17.9% |
| Balance Sheet | |||||||||||||||||
| Debt/Equity | 9.85 | 9.85 | 0.93 | 0.16 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — | — | — |
| Current Ratio | 0.73 | 0.73 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||
| Free Cash Flow | $-9.0M | $-9.0M | $-19.6M | $-9.8M | $87000.00 | $5.9M | $6.8M | $9.5M | $625974.00 | $-849098.00 | $-1.3M | — | $8.1M | $1.6M | $-7626.00 | $4.0M | $305630.00 |
| Returns | |||||||||||||||||
| ROE | -835.8% | -835.8% | -180.7% | -54.4% | -32.2% | 1.1% | 24.2% | 7.9% | -11.2% | -2.5% | -3.7% | 25.5% | 11.6% | 5.1% | 6.5% | 24.8% | 28.9% |
| Valuation | |||||||||||||||||
| EV/EBITDA | — | — | — | — | 98.15 | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 43.87 | 43.87 | 9.46 | 2.18 | 1.95 | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||
| Revenue Growth | 69.8% | 69.8% | -48.6% | -13.6% | — | — | — | — | 29.5% | 24.2% | -2.5% | -31.7% | 43.9% | 15.5% | -44.2% | 58.8% | — |
| EPS Growth | 44.4% | 44.4% | -44.0% | -13.6% | — | -94.3% | 337.5% | 166.7% | -300.0% | 25.0% | -113.8% | 190.0% | 150.0% | 0.0% | -73.3% | 50.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+29.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.72 → -0.40
Residual
+29.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.